Sight Sciences Net Income
| SGHT Stock | USD 5.53 0.24 4.16% |
As of the 12th of February 2026, Sight Sciences has the Coefficient Of Variation of 1815.47, risk adjusted performance of 0.052, and Semi Deviation of 3.93. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sight Sciences, as well as the relationship between them.
Sight Sciences Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.4603 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -46.4 M | -48.7 M | |
| Net Loss | -77.6 M | -73.7 M | |
| Net Loss | -46.4 M | -48.7 M | |
| Net Loss | (1.18) | (1.24) | |
| Net Income Per E B T | 0.90 | 0.80 |
Sight | Net Income | Build AI portfolio with Sight Stock |
The evolution of Net Income for Sight Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Sight Sciences compares to historical norms and industry peers.
Latest Sight Sciences' Net Income Growth Pattern
Below is the plot of the Net Income of Sight Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Sight Sciences financial statement analysis. It represents the amount of money remaining after all of Sight Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Sight Sciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sight Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (51.51 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Sight Net Income Regression Statistics
| Arithmetic Mean | (31,791,671) | |
| Coefficient Of Variation | (71.15) | |
| Mean Deviation | 19,227,966 | |
| Median | (14,290,000) | |
| Standard Deviation | 22,620,138 | |
| Sample Variance | 511.7T | |
| Range | 72M | |
| R-Value | (0.77) | |
| Mean Square Error | 218.5T | |
| R-Squared | 0.60 | |
| Significance | 0.0003 | |
| Slope | (3,468,939) | |
| Total Sum of Squares | 8186.7T |
Sight Net Income History
Other Fundumenentals of Sight Sciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Sight Sciences Net Income component correlations
Sight Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Sight Sciences is extremely important. It helps to project a fair market value of Sight Stock properly, considering its historical fundamentals such as Net Income. Since Sight Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sight Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sight Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Sight introduce new products? Factors like these will boost the valuation of Sight Sciences. If investors know Sight will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sight Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of Sight Sciences is measured differently than its book value, which is the value of Sight that is recorded on the company's balance sheet. Investors also form their own opinion of Sight Sciences' value that differs from its market value or its book value, called intrinsic value, which is Sight Sciences' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sight Sciences' market value can be influenced by many factors that don't directly affect Sight Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sight Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sight Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sight Sciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Sight Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sight Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sight Sciences.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Sight Sciences on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Sight Sciences or generate 0.0% return on investment in Sight Sciences over 90 days. Sight Sciences is related to or competes with CVRx, Senseonics Holdings, 908 Devices, Quanterix Corp, SANUWAVE Health,, Cerus, and Lifecore Biomedical. Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical... More
Sight Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sight Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sight Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.15 | |||
| Information Ratio | 0.0331 | |||
| Maximum Drawdown | 25.08 | |||
| Value At Risk | (7.03) | |||
| Potential Upside | 9.34 |
Sight Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sight Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sight Sciences' standard deviation. In reality, there are many statistical measures that can use Sight Sciences historical prices to predict the future Sight Sciences' volatility.| Risk Adjusted Performance | 0.052 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0374 | |||
| Treynor Ratio | 0.0924 |
Sight Sciences February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.052 | |||
| Market Risk Adjusted Performance | 0.1024 | |||
| Mean Deviation | 3.46 | |||
| Semi Deviation | 3.93 | |||
| Downside Deviation | 4.15 | |||
| Coefficient Of Variation | 1815.47 | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.07 | |||
| Information Ratio | 0.0331 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0374 | |||
| Treynor Ratio | 0.0924 | |||
| Maximum Drawdown | 25.08 | |||
| Value At Risk | (7.03) | |||
| Potential Upside | 9.34 | |||
| Downside Variance | 17.26 | |||
| Semi Variance | 15.42 | |||
| Expected Short fall | (3.72) | |||
| Skewness | 0.8585 | |||
| Kurtosis | 1.6 |
Sight Sciences Backtested Returns
Sight Sciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0967, which indicates the firm had a -0.0967 % return per unit of risk over the last 3 months. Sight Sciences exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sight Sciences' Risk Adjusted Performance of 0.052, coefficient of variation of 1815.47, and Semi Deviation of 3.93 to confirm the risk estimate we provide. The entity has a beta of 2.69, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sight Sciences will likely underperform. At this point, Sight Sciences has a negative expected return of -0.35%. Please make sure to validate Sight Sciences' downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Sight Sciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.81 |
Excellent reverse predictability
Sight Sciences has excellent reverse predictability. Overlapping area represents the amount of predictability between Sight Sciences time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sight Sciences price movement. The serial correlation of -0.81 indicates that around 81.0% of current Sight Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.81 | |
| Spearman Rank Test | -0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.58 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Sight Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Sight Sciences reported net income of (51.51 Million). This is 115.09% lower than that of the Health Care Equipment & Supplies sector and 121.63% lower than that of the Health Care industry. The net income for all United States stocks is 109.02% higher than that of the company.
Sight Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sight Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sight Sciences could also be used in its relative valuation, which is a method of valuing Sight Sciences by comparing valuation metrics of similar companies.Sight Sciences is currently under evaluation in net income category among its peers.
Sight Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sight Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sight Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Sight Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Sight Sciences that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Sight Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sight Sciences' value.| Shares | Northern Trust Corp | 2025-06-30 | 340.4 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 333.4 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 300.6 K | Charles Schwab Investment Management Inc | 2025-06-30 | 266.3 K | D. E. Shaw & Co Lp | 2025-06-30 | 253.8 K | Gotham Asset Management, Llc | 2025-06-30 | 156.5 K | Jpmorgan Chase & Co | 2025-06-30 | 133.7 K | Bank Of America Corp | 2025-06-30 | 105.7 K | Bridgeway Capital Management, Llc | 2025-06-30 | 96.4 K | Kck Ltd | 2025-06-30 | 4.4 M | Long Focus Capital Management, Llc | 2025-06-30 | 3.2 M |
Sight Fundamentals
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.61) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 262.37 M | ||||
| Shares Outstanding | 52.87 M | ||||
| Shares Owned By Insiders | 21.69 % | ||||
| Shares Owned By Institutions | 49.34 % | ||||
| Number Of Shares Shorted | 1.09 M | ||||
| Price To Book | 4.90 X | ||||
| Price To Sales | 4.01 X | ||||
| Revenue | 79.87 M | ||||
| Gross Profit | 65.44 M | ||||
| EBITDA | (45.9 M) | ||||
| Net Income | (51.51 M) | ||||
| Cash And Equivalents | 220.1 M | ||||
| Cash Per Share | 4.60 X | ||||
| Total Debt | 40.36 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 16.73 X | ||||
| Book Value Per Share | 1.23 X | ||||
| Cash Flow From Operations | (22.35 M) | ||||
| Short Ratio | 3.52 X | ||||
| Earnings Per Share | (0.90) X | ||||
| Target Price | 9.35 | ||||
| Number Of Employees | 216 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 305.07 M | ||||
| Total Asset | 142.84 M | ||||
| Retained Earnings | (346.3 M) | ||||
| Working Capital | 124.31 M | ||||
| Net Asset | 142.84 M |
About Sight Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sight Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sight Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sight Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.